பிரிவு ஆஃப் உள் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரிவு ஆஃப் உள் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரிவு ஆஃப் உள் மருந்து Today - Breaking & Trending Today

Jaguar Health, Inc.: Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting


(0)
SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea ( CRD ) by Napo Pharmaceuticals, Inc. ( Napo ), Jaguar s wholly owned subsidiary, and Napo s collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO
®) Annual Meeting, which will be held virtually from June 4-8, 2021. In addition, two CRD-related abstracts from Napo and its collaborators have been accepted for online publication at ASCO.
Abstract accepted for poster presentation:
The impact of cancer-related diarrhea on changes in cancer therapy patterns: Real world evidence ....

United States , University Of Texas , Lee Schwartzberg , Eric Roeland , Pabloc Okhuysen , Peter Hodge , Division Of Internal Medicine , Society Scientific Program Committee , American Society Of Clinical Oncology , Jaguar Health Inc , Cancer Center , Md Anderson Cancer Center , Harvard Medical School , Department Of Infectious Diseases , Exchange Commission , Employee Health , Napo Pharmaceuticals Inc , Jaguar Health , Napo Pharmaceuticals , American Society , Clinical Oncology , Annual Meeting , Infectious Diseases , Infection Control , Internal Medicine , Executive Director ,

Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting


Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting
ACCESSWIRE
20 May 2021, 22:43 GMT+10
SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced the highlights of the abstract regarding patient outcomes associated with cancer-related diarrhea ( CRD ) by Napo Pharmaceuticals, Inc. ( Napo ), Jaguar s wholly owned subsidiary, and Napo s collaborators that has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO
®) Annual Meeting, which will be held virtually from June 4-8, 2021. In addition, two CRD-related abstracts from Napo and its collaborators have been accepted for online publication at ASCO. ....

United States , University Of Texas , Lee Schwartzberg , Eric Roeland , Pabloc Okhuysen , Peter Hodge , Division Of Internal Medicine , Society Scientific Program Committee , American Society Of Clinical Oncology , Jaguar Health Inc , Cancer Center , Md Anderson Cancer Center , Harvard Medical School , Department Of Infectious Diseases , Exchange Commission , Employee Health , Napo Pharmaceuticals Inc , Jaguar Health , Napo Pharmaceuticals , American Society , Clinical Oncology , Annual Meeting , Infectious Diseases , Infection Control , Internal Medicine , Executive Director ,